Akoustis Technologies, Inc. Annual Operating Income (Loss) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akoustis Technologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Akoustis Technologies, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.34M, a 75.4% increase year-over-year.
  • Akoustis Technologies, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$93.7M, a 34.3% decline year-over-year.
  • Akoustis Technologies, Inc. annual Operating Income (Loss) for 2024 was -$110M, a 66.5% decline from 2023.
  • Akoustis Technologies, Inc. annual Operating Income (Loss) for 2023 was -$66.1M, a 9.11% decline from 2022.
  • Akoustis Technologies, Inc. annual Operating Income (Loss) for 2022 was -$60.6M, a 46.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$110M -$43.9M -66.5% Jul 1, 2023 Jun 30, 2024 10-K 2024-10-08
2023 -$66.1M -$5.51M -9.11% Jul 1, 2022 Jun 30, 2023 10-K 2024-10-08
2022 -$60.6M -$19.2M -46.3% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-06
2021 -$41.4M -$9.36M -29.2% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-12
2020 -$32M -$4.47M -16.2% Jul 1, 2019 Jun 30, 2020 10-K 2021-08-30
2019 -$27.6M -$5.29M -23.7% Jul 1, 2018 Jun 30, 2019 10-K 2020-08-21
2018 -$22.3M -$11.6M -109% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-13
2017 -$10.7M -$6.24M -141% Jul 1, 2016 Jun 30, 2017 10-K 2018-08-29
2016 -$4.44M -$569K -14.7% Jul 1, 2015 Jun 30, 2016 10-K/A 2017-09-26
2015 -$3.87M -$3.29M -563% Apr 1, 2015 Mar 31, 2016 10-KT 2016-10-31
2014 -$584K +$6.22M +91.4% May 13, 2014 Mar 31, 2015 10-KT 2016-10-31
2013 -$6.8M Apr 10, 2013 Apr 30, 2014 10-Q 2014-06-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.